USE OF THIAZOLIDINONE DERIVATIVES AS ANTIANGIOGENIC AGENTS
The invention relates to the use of compounds of general formula (I), in which R1, R2 and X are as defined in the description for the preparation of pharmaceutical compositions for the treatment of pathologies in which inhibition of the interaction between HIF-1α and p300 is beneficial, in particular as antiangiogenic medicaments for the therapy of solid tumors.
-
Page/Page column 14
(2008/06/13)
More Articles about upstream products of 23522-20-5
